SK609, a novel dopamine D3 receptor agonist and norepinephrine transporter blocker with pro-cognitive actions, does not induce psychostimulant-like increases in risky choice during probabilistic discounting
Christopher P. Knapp, Brooke Fallon, Sandhya Kortagere, Barry D. Waterhouse, S. B. Floresco, Rachel L. Navarra
This study compares the effects of SK609, a novel dopamine D3 receptor agonist and norepinephrine transporter blocker, with amphetamine and methylphenidate on risky choice behavior in a probabilistic discounting task.
Psychopharmacology · Dec 4, 2024Peer-reviewedAnimal Behavior & Cognition